{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:21:06Z","timestamp":1790072466007,"version":"4.0.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome Trust Strategic Award","award":["098330\/Z\/12\/Z"],"award-info":[{"award-number":["098330\/Z\/12\/Z"]}]},{"name":"London Down Syndrome (LonDownS) Consortium"},{"name":"Wellcome Trust Joint Senior Investigators Award"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["U117527252"],"award-info":[{"award-number":["U117527252"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0601056"],"award-info":[{"award-number":["G0601056"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer\u2019s Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000295","name":"Epilepsy Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Torsten S\u00f6derberg Foundation at the Royal Swedish Academy of Sciences"},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["FC001194"],"award-info":[{"award-number":["FC001194"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001194"],"award-info":[{"award-number":["FC001194"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001194"],"award-info":[{"award-number":["FC001194"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/brain\/awy159","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T07:08:37Z","timestamp":1527059317000},"page":"2457-2474","source":"Crossref","is-referenced-by-count":133,"title":["Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of\n                    <i>APP<\/i>"],"prefix":"10.1093","volume":"141","author":[{"given":"Frances K","family":"Wiseman","sequence":"first","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"},{"name":"The LonDownS Consortium, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, Denmark Hill, London, SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Pulford","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Barkus","sequence":"additional","affiliation":[{"name":"Department of Experimental Psychology, University of Oxford, Oxford, OX1 3PH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri, 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Portelius","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, S-405 30, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Webb","sequence":"additional","affiliation":[{"name":"Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, 40507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ch\u00e1vez-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"VIB-KU Leuven Center for Brain and Disease Research, VIB-Leuven 3000, Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cleverley","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Noy","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Powell","sequence":"additional","affiliation":[{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, 33 Cleveland Street, London W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J","family":"Sarell","sequence":"additional","affiliation":[{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, 33 Cleveland Street, London W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rickman","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Choong","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L","family":"Tosh","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Siganporia","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather T","family":"Whittaker","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floy","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri, 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Szaruga","sequence":"additional","affiliation":[{"name":"VIB-KU Leuven Center for Brain and Disease Research, VIB-Leuven 3000, Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"London Down syndrome consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Murphy","sequence":"additional","affiliation":[{"name":"Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, 40507, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, S-405 30, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Strooper","sequence":"additional","affiliation":[{"name":"VIB-KU Leuven Center for Brain and Disease Research, VIB-Leuven 3000, Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, Leuven, Belgium"},{"name":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N 3BG, UK"},{"name":"UK Dementia Research Institute, London, WC2B 4AN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, S-405 30, Sweden"},{"name":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N 3BG, UK"},{"name":"UK Dementia Research Institute, London, WC2B 4AN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bannerman","sequence":"additional","affiliation":[{"name":"Department of Experimental Psychology, University of Oxford, Oxford, OX1 3PH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Holtzman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri, 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L J","family":"Tybulewicz","sequence":"additional","affiliation":[{"name":"The LonDownS Consortium, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, Denmark Hill, London, SE5 8AF, UK"},{"name":"Francis Crick Institute, London, NW1 1AT, UK"},{"name":"Department of Medicine, Imperial College, London, SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M C","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG UK"},{"name":"The LonDownS Consortium, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, Denmark Hill, London, SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The LonDownS Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Nizetic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Tybulewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Karmiloff-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"key\n\t\t\t\t2019031803262996400_awy159-B1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1471-4159.2009.06528.x","article-title":"BACE1 and BACE2 enzymatic activities in Alzheimer\u2019s disease","volume":"112","author":"Ahmed","year":"2010","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrk1 inhibition improves Alzheimer\u2019s disease-like pathology","volume":"16","author":"Branca","year":"2017","journal-title":"Aging Cell"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B3","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1371\/journal.pgen.0020086","article-title":"Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization","volume":"2","author":"Brault","year":"2006","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B4","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","article-title":"Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome","volume":"25","author":"Cataldo","year":"2004","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B7","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Chavez-Gutierrez","year":"2012","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B8","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.M803040200","article-title":"Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity","volume":"283","author":"Chavez-Gutierrez","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00726-007-0618-9","article-title":"Protein expression of BACE1, BACE2 and APP in Down syndrome brains","volume":"35","author":"Cheon","year":"2008","journal-title":"Amino Acids"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","article-title":"Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway","volume":"79","author":"Das","year":"2013","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/BJ20061451","article-title":"Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins","volume":"404","author":"Dorval","year":"2007","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004010050963","article-title":"Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down\u2019s syndrome versus sporadic\/familial Alzheimer\u2019s disease","volume":"97","author":"Egensperger","year":"1999","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer\u2019s disease phenotypes","volume":"106","author":"Garcia-Cerro","year":"2017","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2015.10.083","article-title":"Improved survival in Down syndrome over the last 60 years and the impact of perinatal factors in recent decades","volume":"169","author":"Glasson","year":"2016","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B17","doi-asserted-by":"crossref","first-page":"e60482","DOI":"10.1371\/journal.pone.0060482","article-title":"Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome","volume":"8","author":"Gribble","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","article-title":"Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome","volume":"125","author":"Gyure","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B19","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nlm.2016.02.002","article-title":"Tc1 mouse model of trisomy-21 dissociates properties of short- and long-term recognition memory","volume":"130","author":"Hall","year":"2016","journal-title":"Neurobiol Learn Mem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0387-7604(02)00209-7","article-title":"Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome","volume":"25","author":"Hirayama","year":"2003","journal-title":"Brain Dev"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B22","doi-asserted-by":"crossref","first-page":"e66381","DOI":"10.1371\/journal.pone.0066381","article-title":"Evaluating amyloid-beta oligomers in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease","volume":"8","author":"Holtta","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbrc.2009.05.131","article-title":"Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein","volume":"386","author":"Hook","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.1995.00540280059019","article-title":"Neuropathological changes in Down\u2019s syndrome hippocampal formation. Effect of age and apolipoprotein E genotype","volume":"52","author":"Hyman","year":"1995","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B25","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B26","doi-asserted-by":"crossref","first-page":"10673","DOI":"10.1073\/pnas.0700148104","article-title":"Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity","volume":"104","author":"Kang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","volume":"26","author":"Lalonde","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B28","doi-asserted-by":"crossref","first-page":"e11614","DOI":"10.7554\/eLife.11614","article-title":"Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel","volume":"5","author":"Lana-Elola","year":"2016","journal-title":"Elife"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1242\/dmm.008078","article-title":"Down syndrome: searching for the genetic culprits","volume":"4","author":"Lana-Elola","year":"2011","journal-title":"Dis Model Mech"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/exnr.1997.6777","article-title":"Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis","volume":"150","author":"Leverenz","year":"1998","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1073\/pnas.0235361100","article-title":"Positive and negative regulation of APP amyloidogenesis by sumoylation","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","article-title":"Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"13","author":"Mann","year":"1988","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2014","journal-title":"J Intellect Disabil Res"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B35","doi-asserted-by":"crossref","first-page":"1513.e1","DOI":"10.1016\/j.neurobiolaging.2013.12.022","article-title":"Polymorphisms in BACE2 may affect the age of onset Alzheimer\u2019s dementia in Down syndrome","volume":"35","author":"Mok","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/13506120208995241","article-title":"Intraneuronal Abeta42 accumulation in Down syndrome brain","volume":"9","author":"Mori","year":"2002","journal-title":"Amyloid"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1101\/lm.969608","article-title":"Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome","volume":"15","author":"Morice","year":"2008","journal-title":"Learn Mem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B38","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer\u2019s disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000323871","article-title":"Characterization of the brain beta-amyloid isoform pattern at different ages of Tg2576 mice","volume":"8","author":"Mustafiz","year":"2011","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B41","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1126\/science.1114535","article-title":"An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes","volume":"309","author":"O\u2019Doherty","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.a.32729","article-title":"The phenotype of persons having mosaicism for trisomy 21\/Down syndrome reflects the percentage of trisomic cells present in different tissues","volume":"149A","author":"Papavassiliou","year":"2009","journal-title":"Am J Med Genet A"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B43","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/cne.22573","article-title":"Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome","volume":"519","author":"Popov","year":"2011","journal-title":"J Comp Neurol"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer\u2019s disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1037\/0735-7044.121.3.559","article-title":"Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory","volume":"121","author":"Sanderson","year":"2007","journal-title":"Behav Neurosci"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","article-title":"Restricted location of PSEN2\/gamma-secretase determines substrate specificity and generates an intracellular abeta pool","volume":"166","author":"Sannerud","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","article-title":"Biochemical and immunohistochemical analysis of an Alzheimer\u2019s disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life","volume":"36","author":"Shankar","year":"2009","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B51","doi-asserted-by":"crossref","first-page":"828.e31","DOI":"10.1016\/j.neurobiolaging.2011.06.025","article-title":"Altered regulation of tau phosphorylation in a mouse model of down syndrome aging","volume":"33","author":"Sheppard","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B52","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12688\/wellcomeopenres.9961.1","article-title":"The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome","volume":"1","author":"Startin","year":"2016","journal-title":"Wellcome Open Res"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1096\/fj.05-5632com","article-title":"BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer\u2019s disease in Down syndrome","volume":"20","author":"Sun","year":"2006","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B55","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human gamma-secretase underlie familial Alzheimer\u2019s disease","volume":"212","author":"Szaruga","year":"2015","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B56","doi-asserted-by":"crossref","first-page":"52, 54","DOI":"10.2144\/00291bm09","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B57","doi-asserted-by":"crossref","first-page":"36732","DOI":"10.1074\/jbc.M112.394635","article-title":"Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-beta peptide pool","volume":"287","author":"Vandersteen","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B58","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1021\/acs.biochem.5b00329","article-title":"Cathepsin L mediates the degradation of novel APP C-terminal fragments","volume":"54","author":"Wang","year":"2015","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B59","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B61","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nn.4072","article-title":"Hippocampal circuit dysfunction in the Tc1 mouse model of Down syndrome","volume":"18","author":"Witton","year":"2015","journal-title":"Nat Neurosci"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B62","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","article-title":"The population prevalence of Down\u2019s syndrome in England and Wales in 2011","volume":"21","author":"Wu","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B63","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","article-title":"Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing abeta generation and amyloid plaque pathogenesis","volume":"35","author":"Xiao","year":"2015","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/brain\/awq341","article-title":"Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits","volume":"134","author":"Yang","year":"2011","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B65","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/gim.2012.93","article-title":"Survival among people with Down syndrome: a nationwide population-based study in Denmark","volume":"15","author":"Zhu","year":"2013","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t2019031803262996400_awy159-B67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2017.08.024","article-title":"Clinical aspects and biomarkers of Alzheimer\u2019s disease in Down syndrome","volume":"114","author":"Zis","year":"2018","journal-title":"Free Radic Biol Med"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/141\/8\/2457\/28083739\/awy159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T21:22:19Z","timestamp":1661289739000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/141\/8\/2457\/5043552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,6,26]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awy159","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733504832.793565311","asserted-by":"object"}]},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,6,26]]}}}